Mark C. Gebhardt

27.3k total citations · 7 hit papers
232 papers, 17.8k citations indexed

About

Mark C. Gebhardt is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Mark C. Gebhardt has authored 232 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Pulmonary and Respiratory Medicine, 88 papers in Rheumatology and 85 papers in Surgery. Recurrent topics in Mark C. Gebhardt's work include Sarcoma Diagnosis and Treatment (151 papers), Bone Tumor Diagnosis and Treatments (75 papers) and Management of metastatic bone disease (32 papers). Mark C. Gebhardt is often cited by papers focused on Sarcoma Diagnosis and Treatment (151 papers), Bone Tumor Diagnosis and Treatments (75 papers) and Management of metastatic bone disease (32 papers). Mark C. Gebhardt collaborates with scholars based in United States, Canada and Japan. Mark C. Gebhardt's co-authors include Henry J. Mankin, Francis J. Hornicek, Dempsey S. Springfield, Douglas Pritchard, L. Candace Jennings, William W. Tomford, Holcombe E. Grier, Daniel I. Rosenthal, Andrew E. Rosenberg and Michael P. Link and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mark C. Gebhardt

229 papers receiving 17.2k citations

Hit Papers

A System for the Functional Evaluation of Reconstructive ... 1988 2026 2000 2013 1993 2003 1990 1996 2004 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System
    1993 1.8k citations Mark C. Gebhardt et al. Clinical Orthopaedics and Related Research profile →
  2. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone
    2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →
  3. p53 functions as a cell cycle control protein in osteosarcomas.
    1990 677 citations Lisa Diller, J Kassel et al. Molecular and Cellular Biology profile →
  4. Long-Term Results of Allograft Replacement in the Management of Bone Tumors
    1996 536 citations Henry J. Mankin, Mark C. Gebhardt et al. Clinical Orthopaedics and Related Research profile →
  5. Biology and Therapeutic Advances for Pediatric Osteosarcoma
    2004 535 citations Neyssa Marina, Mark C. Gebhardt et al. profile →
  6. Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
    2008 520 citations Paul A. Meyers, Cindy L. Schwartz et al. Journal of Clinical Oncology profile →
  7. Infection in bone allografts. Incidence, nature, and treatment.
    1988 379 citations Mark C. Gebhardt, Henry J. Mankin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Gebhardt United States 69 11.5k 7.4k 6.6k 3.8k 2.1k 232 17.8k
Alberto G. Ayala United States 70 10.5k 0.9× 6.9k 0.9× 7.1k 1.1× 4.2k 1.1× 2.7k 1.3× 434 18.8k
R. J. Grimer United Kingdom 65 11.2k 1.0× 6.7k 0.9× 6.0k 0.9× 3.1k 0.8× 1.1k 0.5× 324 15.0k
Francis J. Hornicek United States 71 9.2k 0.8× 6.8k 0.9× 5.3k 0.8× 4.6k 1.2× 4.6k 2.1× 453 19.4k
Jay S. Wunder Canada 64 11.1k 1.0× 6.4k 0.9× 4.8k 0.7× 5.6k 1.5× 2.1k 1.0× 350 15.7k
Andrew E. Rosenberg United States 72 8.7k 0.8× 7.9k 1.1× 3.7k 0.6× 3.5k 0.9× 1.2k 0.5× 389 15.4k
Louis P. Dehner United States 75 7.5k 0.7× 5.3k 0.7× 7.9k 1.2× 3.4k 0.9× 3.6k 1.7× 441 20.4k
Cyril Fisher United Kingdom 75 13.0k 1.1× 6.1k 0.8× 4.0k 0.6× 8.1k 2.1× 2.5k 1.1× 410 20.5k
John R. Goldblum United States 79 12.4k 1.1× 4.7k 0.6× 9.7k 1.5× 5.7k 1.5× 2.0k 0.9× 362 22.7k
Henry J. Mankin United States 90 12.9k 1.1× 16.5k 2.2× 12.5k 1.9× 4.8k 1.3× 4.3k 2.0× 494 33.0k
Angelo Paolo Dei Tos Italy 67 10.9k 1.0× 4.5k 0.6× 3.4k 0.5× 6.1k 1.6× 2.5k 1.2× 438 17.0k

Countries citing papers authored by Mark C. Gebhardt

Since Specialization
Citations

This map shows the geographic impact of Mark C. Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Gebhardt more than expected).

Fields of papers citing papers by Mark C. Gebhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Gebhardt. The network helps show where Mark C. Gebhardt may publish in the future.

Co-authorship network of co-authors of Mark C. Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Gebhardt. A scholar is included among the top collaborators of Mark C. Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Gebhardt. Mark C. Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nazarian, Ara, Vahid Entezari, David Zurakowski, et al.. (2015). Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis. Clinical Cancer Research. 21(11). 2514–2519. 38 indexed citations
2.
Evans, Christopher H., Fangjun Liu, Ryan M. Porter, et al.. (2012). EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors. Clinical Cancer Research. 18(19). 5341–5351. 39 indexed citations
3.
Kurek, Kyle C., Sara Del Mare, Zaidoun Salah, et al.. (2010). Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression. Cancer Research. 70(13). 5577–5586. 90 indexed citations
4.
Granowetter, Linda, Richard B. Womer, Meenakshi Devidas, et al.. (2009). Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology. 27(15). 2536–2541. 235 indexed citations
5.
Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638. 520 indexed citations breakdown →
6.
Sung, Anthony D., Megan E. Anderson, David Zurakowski, Francis J. Hornicek, & Mark C. Gebhardt. (2008). Unicameral Bone Cyst: A Retrospective Study of Three Surgical Treatments. Clinical Orthopaedics and Related Research. 466(10). 2519–2526. 76 indexed citations
7.
Yock, Torunn I., Mark Krailo, Christopher Fryer, et al.. (2006). Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 24(24). 3838–3843. 100 indexed citations
8.
Kępka, Lucyna, Herman D. Suit, Saveli Goldberg, et al.. (2005). Radiation Therapy for Control of Soft Tissue Sarcomas Resected with Positive Margins. International Journal of Radiation Oncology*Biology*Physics. 63. S47–S48. 113 indexed citations
9.
Shamberger, Robert C., Michael P. LaQuaglia, Mark C. Gebhardt, et al.. (2003). Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall. Annals of Surgery. 238(4). 563–568. 75 indexed citations
10.
DeLaney, Thomas F., Ira J. Spiro, Herman D. Suit, et al.. (2003). Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1117–1127. 224 indexed citations
11.
Quinn, Robert H., Henry J. Mankin, Dempsey S. Springfield, & Mark C. Gebhardt. (2001). Management of Infected Bulk Allografts With Antibiotic-Impregnated Polymethylmethacrylate Spacers. Orthopedics. 24(10). 971–975. 9 indexed citations
12.
Ferguson, William S., Michael B. Harris, Allen M. Goorin, et al.. (2001). Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial. ˜The œAmerican journal of pediatric hematology/oncology. 23(6). 340–348. 52 indexed citations
13.
Kocher, Mininder S., et al.. (2000). Multiple Lytic Skeletal Lesions and Hypercalcemia in a 13-Year-Old Girl. Clinical Orthopaedics and Related Research. 374(374). 298–302, 317. 11 indexed citations
14.
McLean, Thomas W., Mary Lynn Young, Karen Marcus, et al.. (1999). Late Events in Pediatric Patients With Ewing Sarcoma/Primitive Neuroectodermal Tumor of Bone. Journal of Pediatric Hematology/Oncology. 21(6). 486–493. 41 indexed citations
15.
Skapek, Stephen X., Fredric A. Hoffer, Gary V. Dahl, et al.. (1998). Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.. Journal of Clinical Oncology. 16(9). 3021–3027. 105 indexed citations
16.
Hovig, Eivind, Birgitte Smith‐Sørensen, Mark C. Gebhardt, et al.. (1992). No alterations in exon 21 of the RBI gene in sarcomas and carcinomas of the breast, colon, and lung. Genes Chromosomes and Cancer. 5(2). 97–103. 8 indexed citations
17.
Mankin, Henry J., Dempsey S. Springfield, & Mark C. Gebhardt. (1991). Principles of Surgical Treatment of Soft Tissue Sarcomas. Cancer treatment and research. 56. 37–52. 2 indexed citations
18.
Diller, Lisa, J Kassel, Mark C. Gebhardt, et al.. (1990). p53 Functions as a Cell Cycle Control Protein in Osteosarcomas. Molecular and Cellular Biology. 10(11). 5772–5781. 209 indexed citations
19.
Fisher, Bernard, et al.. (1978). Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(1). 38–41. 2 indexed citations
20.
Fisher, Bernard, et al.. (1978). Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2679–87. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto G. Ayala Breakdown of academic impact, for papers by R. J. Grimer Breakdown of academic impact, for papers by Francis J. Hornicek Breakdown of academic impact, for papers by Jay S. Wunder Breakdown of academic impact, for papers by Andrew E. Rosenberg Breakdown of academic impact, for papers by Louis P. Dehner Breakdown of academic impact, for papers by Cyril Fisher Breakdown of academic impact, for papers by John R. Goldblum Breakdown of academic impact, for papers by Henry J. Mankin Breakdown of academic impact, for papers by Angelo Paolo Dei Tos
Rankless by CCL
2026